In addition, due to the association of FAP with worse prognosis, invasion, metastasis, and treatment resistance in several cancers, the expression level of the FAP marker can be used as a biomarker in determining prognosis, recurrence, and diagnosis of tumor status. This evidence concerns the gene FAP and neoplasm.